These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 38818077)
1. CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets. Zhang W; Liu Y; Jang H; Nussinov R JACS Au; 2024 May; 4(5):1911-1927. PubMed ID: 38818077 [TBL] [Abstract][Full Text] [Related]
2. Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2. Zhang W; Liu Y; Jang H; Nussinov R bioRxiv; 2023 Aug; ():. PubMed ID: 37790340 [TBL] [Abstract][Full Text] [Related]
3. Slower CDK4 and faster CDK2 activation in the cell cycle. Zhang W; Liu Y; Jang H; Nussinov R Structure; 2024 Aug; 32(8):1269-1280.e2. PubMed ID: 38703777 [TBL] [Abstract][Full Text] [Related]
4. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes. Sarcevic B; Lilischkis R; Sutherland RL J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125 [TBL] [Abstract][Full Text] [Related]
5. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors. Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583 [TBL] [Abstract][Full Text] [Related]
6. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267 [TBL] [Abstract][Full Text] [Related]
7. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745 [TBL] [Abstract][Full Text] [Related]
8. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Matsuoka M; Kato JY; Fisher RP; Morgan DO; Sherr CJ Mol Cell Biol; 1994 Nov; 14(11):7265-75. PubMed ID: 7935441 [TBL] [Abstract][Full Text] [Related]
9. CDK4/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1/S transition. Kim S; Leong A; Kim M; Yang HW Sci Rep; 2022 Oct; 12(1):16810. PubMed ID: 36207346 [TBL] [Abstract][Full Text] [Related]
10. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point. Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759 [TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. Roskoski R Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677 [TBL] [Abstract][Full Text] [Related]
12. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914 [TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Roskoski R Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305 [TBL] [Abstract][Full Text] [Related]
14. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. Obaya AJ; Kotenko I; Cole MD; Sedivy JM J Biol Chem; 2002 Aug; 277(34):31263-9. PubMed ID: 12070150 [TBL] [Abstract][Full Text] [Related]
15. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508 [TBL] [Abstract][Full Text] [Related]
16. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Reynisdóttir I; Polyak K; Iavarone A; Massagué J Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471 [TBL] [Abstract][Full Text] [Related]
17. Network-based modelling and percolation analysis of conformational dynamics and activation in the CDK2 and CDK4 proteins: dynamic and energetic polarization of the kinase lobes may determine divergence of the regulatory mechanisms. Verkhivker GM Mol Biosyst; 2017 Oct; 13(11):2235-2253. PubMed ID: 28926061 [TBL] [Abstract][Full Text] [Related]